Heart : official journal of the British Cardiac Society
-
Randomized Controlled Trial Clinical Trial
Beta blockers in heart failure: a comparison of a vasodilating beta blocker with metoprolol.
To determine whether a third generation vasodilating beta blocker (celiprolol) has long term clinical advantages over metoprolol in patients with chronic heart failure. ⋯ Both drugs were well tolerated but the vasodilator properties of celiprolol do not seem to provide any obvious additional benefit in the long term treatment of heart failure.